You are here

Article info

Article menu

Download PDFPDF

EBM analysis
Primary care
Open-label placebo clinical trials: is it the rationale, the interaction or the pill?

Authors

  • Charlotte R Blease Program in Placebo Studies, Department of General Medicine and Primary Care Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA School of Psychology, University College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Michael H. Bernstein School of Public Health, Department of Behavioral and Social Sciences, Brown University, Providence, Rhode Island, USA PubMed articlesGoogle scholar articles
  • Cosima Locher Department of Clinical Psychology and Psychotherapy, University of Basel, Basel, Switzerland School of Psychology, University of Plymouth, Plymouth, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Charlotte R Blease, General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA; cblease{at}bidmc.harvard.edu
View Full Text

Citation

Blease CR, Bernstein MH, Locher C
Open-label placebo clinical trials: is it the rationale, the interaction or the pill?
BMJ Evidence-Based Medicine 2020;25:159-165.

Publication history

  • Accepted May 30, 2019
  • First published June 26, 2019.
Online issue publication 
September 23, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.